4T8-61215-20785
5 vaccinations
5 coded responses
59 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 030 / NH
- Registered
- 2021-02-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-17
Dose 1 — Pfizer-BioNTech
-
2021-02-19
Registered in v-safe
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-03-03
- 2021-03-10
-
2021-03-17
Dose 2 — Pfizer-BioNTech
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-06-16
- 2021-09-15
-
2021-10-02
Dose 3 — Pfizer-BioNTech
-
2021-10-02
Survey response — day 0, dose 3MedDRA: No adverse event — Feeling: GoodFree text: Not at this timeMedDRA releases: 2024-11 · check-in free text available
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Arthralgia, Back pain, Oedema peripheral — Feeling: Fair · Site: SwellingFree text: The soreness is in the shot area and also a little towards the upper shoulder/back. Under my armpit of the arm that received the shot is a little swollenMedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Injection site pain, Oedema peripheral — Feeling: Fair · Site: SwellingFree text: Soreness in shot area and swelling under armpit of shot armMedDRA releases: 2024-11 · check-in free text available
- 2021-10-05
-
2021-10-06
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Redness · HeadacheFree text: Still have swollen lymph nodes in armpit of arm that received shotMedDRA releases: 2024-11 · check-in free text available
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-11-01
- 2021-11-06
- 2021-11-13
- 2022-01-01
- 2022-04-02
-
2022-05-18
Dose 4 — Pfizer-BioNTech
- 2022-05-19
- 2022-05-20
- 2022-05-21
- 2022-05-22
- 2022-05-23
- 2022-05-24
- 2022-05-25
- 2022-06-01
- 2022-06-10
- 2022-06-15
- 2022-06-22
- 2022-06-29
- 2022-08-17
-
2022-09-14
Dose 5 — Other-UnknownCo-administered: Flu
-
2022-09-23
Survey response — day 7, dose 5MedDRA: Muscle tightness — Feeling: GoodFree text: I had muscle tightness in my left jaw for two days after the shots but am not sure if it was caused by stress or by the shotsMedDRA releases: 2024-11 · check-in free text available
- 2022-09-28
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-12-14
- 2023-03-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-17 | Pfizer-BioNTech | |
| 2 | 2021-03-17 | Pfizer-BioNTech | |
| 3 | 2021-10-02 | Pfizer-BioNTech | No |
| 4 | 2022-05-18 | Pfizer-BioNTech | No |
| 5 | 2022-09-14 | Other-Unknown | Flu |
Free text
Release 9 — day 0, dose 3
Systemic reaction (other): Not at this time
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): The soreness is in the shot area and also a little towards the upper shoulder/back. Under my armpit of the arm that received the shot is a little swollen
Systemic reaction (other): Soreness in shot area and swelling under armpit of shot arm
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Still have swollen lymph nodes in armpit of arm that received shot
Release 12 — day 7, dose 5
Systemic reaction (other): I had muscle tightness in my left jaw for two days after the shots but am not sure if it was caused by stress or by the shots
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Arthralgia | · | · | ✓ |
| SRO | Back pain | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Muscle tightness | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release